Wall Street analysts forecast that Post Holdings (POST) will report quarterly earnings of $1.92 per share in its upcoming release, pointing to a year-over-year increase of 25.5%. It is anticipated that revenues will amount to $2.25 billion, exhibiting an increase of 11.8% compared to the year-ago quarter.The current level reflects a downward revision of 5.1% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraise ...

Nvidia (NVDA) closed the last trading session at $186.86, gaining 2.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $234.12 indicates a 25.3% upside potential.The average comprises 43 short-term price targets ranging from a low of $100.00 to a high of $350.00, with a standard deviation of $44.11. While the lowest estimate indicates a decline of 46.5% from the current price level ...

Group 1 - Heritage Financial (HFWA) shares have increased by 0.5% over the past four weeks, closing at $22.2, with a mean price target of $27.8 indicating a potential upside of 25.2% [1] - The mean estimate consists of five short-term price targets with a standard deviation of $2.05, where the lowest estimate of $26.00 suggests a 17.1% increase, and the highest estimate of $31.00 indicates a 39.6% surge [2] - Analysts show strong agreement on HFWA's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for HFWA's current year earnings has increased by 1% over the last 30 days, with two estimates moving higher and no negative revisions [12] - HFWA holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting the extent of HFWA's gains, they can provide a directional guide for price movement [14]

Core Insights - Viking Holdings (VIK) is expected to report quarterly earnings of $1.19 per share, reflecting a 33.7% increase year-over-year, with revenues projected at $2 billion, a 19.1% increase compared to the previous year [1] - The consensus EPS estimate has remained stable over the last 30 days, indicating analysts have reassessed their initial projections [1][2] Revenue and Earnings Estimates - Analysts estimate 'Onboard and other' revenues will reach $134.85 million, marking an 18.4% increase from the year-ago quarter [4] - The 'Cruise and land' segment is forecasted to generate $1.86 billion, representing a 19.1% increase from the prior-year quarter [4] - 'Occupancy' is projected to be 94.5%, slightly up from 94.0% in the previous year [4] Key Metrics Projections - The 'Net Yield' is expected to reach $613.36, compared to $576.00 from the previous year [5] - 'Capacity PCDs' are projected to be 2,272,497 days, up from 2,030,236 days year-over-year [5] - The average prediction for 'PCDs' stands at 2,148,208 days, an increase from 1,908,364 days in the prior year [5] Stock Performance - Viking shares have seen a -1.1% change over the past month, contrasting with a +1.4% move in the Zacks S&P 500 composite [5] - With a Zacks Rank of 3 (Hold), VIK is anticipated to perform in line with the overall market in the near future [5]

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Pure Storage (PSTG) .Pure Storage currently has an average brokerage recommendation (ABR) of 1. ...

Core Insights - Analysts project Home Depot (HD) will report quarterly earnings of $3.82 per share, reflecting a 1.1% year-over-year increase, with revenues expected to reach $41.07 billion, a 2.1% increase from the same quarter last year [1] Earnings Estimates - The consensus EPS estimate has been revised downward by 0.4% in the past 30 days, indicating a reassessment by covering analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock price performance [3] Key Metrics - Analysts estimate the 'Number of stores - Retail' will reach 2,357, up from 2,345 a year ago [5] - 'Sales per store' is projected to be $17.41 million, compared to $17.15 million from the previous year [5] - The 'Number of customer transactions - Retail' is expected to be 403.35 million, an increase from 399.00 million in the same quarter last year [6] - 'Average ticket - Retail' is anticipated to reach $89.20, up from $88.65 in the same quarter last year [6] Stock Performance - Home Depot shares have shown a return of -4.4% over the past month, contrasting with the Zacks S&P 500 composite's +4.6% change, indicating a potential alignment with overall market performance in the near future [6]

Core Insights - Medtronic (MDT) is expected to report quarterly earnings of $1.31 per share, a 4% increase year-over-year, with revenues projected at $8.86 billion, reflecting a 5.4% increase from the previous year [1] Earnings Estimates - The consensus EPS estimate has been revised down by 0.1% in the last 30 days, indicating a reassessment by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Analysts project 'Net Sales- World Wide Revenue- Diabetes' at $749.45 million, a 9.3% increase year-over-year [5] - 'Net Sales- World Wide Revenue- Neuroscience' is expected to reach $2.49 billion, reflecting a 1.5% increase from the prior year [5] - 'Net Sales- World Wide Revenue- Cardiovascular' is forecasted at $3.36 billion, indicating an 8.5% increase year-over-year [6] - 'Net Sales- World Wide Revenue- Medical Surgical' is anticipated to be $2.24 billion, a 5.4% increase from the previous year [6] - 'Net Sales- U.S. Revenue' is projected at $4.53 billion, reflecting a 5.3% increase year-over-year [6] Specific Segment Estimates - 'Net Sales- U.S. Revenue- Medical Surgical' is expected to be $938.99 million, showing a slight decline of 0.5% year-over-year [7] - 'Net Sales- U.S. Revenue- Neuroscience- Neuromodulation' is projected at $351.65 million, a 5.6% increase from the prior year [7] - 'Net Sales- ROW- Neuroscience- Cranial & Spinal Technologies' is estimated at $326.68 million, indicating a 6.1% increase year-over-year [7] - 'Net Sales- ROW- Neuroscience- Specialty Therapies' is expected to be $319.41 million, reflecting a minimal change of +0.1% year-over-year [8] - 'Net Sales- ROW- Medical Surgical- Surgical & Endoscopy' is projected at $1.03 billion, indicating a 5.4% increase year-over-year [9] - 'Net Sales- ROW- Cardiovascular' is expected to reach $1.80 billion, reflecting a 7.8% increase from the prior year [9] Stock Performance - Over the past month, Medtronic shares have returned +0.5%, compared to the Zacks S&P 500 composite's +4.6% change, suggesting that MDT is likely to perform in line with the overall market [9]

Core Viewpoint - Calix (CALX) has shown a 6.4% increase in stock price over the past four weeks, with a mean price target of $79.5 indicating a potential upside of 26.3% from the current price of $62.94 [1] Price Targets and Analyst Estimates - The mean estimate consists of six short-term price targets with a standard deviation of $5.05, where the lowest estimate is $75.00 (19.2% increase) and the highest is $85.00 (35.1% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about CALX's earnings prospects, with three estimates revised higher in the last 30 days, leading to a Zacks Consensus Estimate increase of 231.4% [12] - CALX holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' ability to set unbiased targets has been questioned [3][7] - Price targets should be treated with skepticism, as they can mislead investors more often than guide them [10]

Core Viewpoint - Analysts expect Aramark (ARMK) to report quarterly earnings of $0.65 per share, reflecting a year-over-year increase of 20.4%, with revenues projected at $5.16 billion, up 16.8% from the previous year [1] Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions to stock performance, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock price performance [2] Revenue Projections - Analysts project 'Revenues- FSS International' to reach $1.44 billion, indicating a 16.1% increase from the year-ago quarter [4] - 'Revenues- FSS United States' is expected to be $3.70 billion, reflecting a 16.5% increase from the previous year [4] Operating Income Estimates - The consensus for 'Operating Income- FSS United States' is $262.33 million, up from $200.72 million in the same quarter last year [4] - 'Operating Income- FSS International' is projected at $65.69 million, compared to $46.21 million a year ago [5] - The estimated 'Adjusted Operating Income- FSS United States' stands at $284.23 million, up from $240.63 million in the previous year [5] - 'Adjusted Operating Income- FSS International' is expected to be $71.16 million, compared to $57.80 million last year [6] Stock Performance - Over the past month, Aramark shares have returned -4.6%, contrasting with the Zacks S&P 500 composite's +4.6% change [6] - Currently, ARMK holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the overall market in the near future [6]

Analysts on Wall Street project that Sally Beauty (SBH) will announce quarterly earnings of $0.49 per share in its forthcoming report, representing a decline of 2% year over year. Revenues are projected to reach $933 million, declining 0.2% from the same quarter last year.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Prior to a company's earnings ann ...